Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
Atopic Dermatitis
How do you manage atopic dermatitis in patients who have failed dupilumab?
Related Questions
How do you weigh the risks/benefits of cytokine blockade (eg dupilumab) in pregnant patients?
Have you seen CD30+ lymphoproliferative skin lesions with Upadacitinib treatment of atopic dermatitis?
What is your approach to managing moderate to severe atopic dermatitis in pregnancy?
How does omalizumab play a role in the armamentarium of atopic dermatitis?
Do you utilize AIT for atopic dermatitis if there is no AR present?
When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
What criteria do you utilize in deciding between different jak inhibitors for atopic dermatitis?
How do you decide between IL-4/IL-13 blockade (dupixent) versus IL-13 blockade only (Adbry) as treatments for Atopic Dermatitis?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
What is the longest interval that you have been able to stretch a biologic before losing efficacy?
